Hawkins, Inc.

Hawkins, Inc. (HWKN) Market Cap

Hawkins, Inc. has a market capitalization of $2.67B.

Price: $128.03

-1.19 (-0.92%)

Market Cap: 2.67B

NASDAQ · time unavailable

CEO: Patrick H. Hawkins

Sector: Basic Materials

Industry: Chemicals - Specialty

IPO Date: 1980-03-18

Website: https://www.hawkinsinc.com

Hawkins, Inc. (HWKN) - Company Information

Market Cap: 2.67B|Sector: Basic Materials

Company Profile

Hawkins, Inc. is an enterprise engaged in the formulation, production, and distribution of chemicals and specialized ingredients, serving both domestic and international markets. Its operations are divided into three principal divisions: Industrial, Water Treatment, and Health and Nutrition. The Industrial division supplies industrial-grade chemicals, associated products, and services to a diverse array of sectors, including agriculture, chemical processing, electronics, energy, food production, pharmaceuticals, and plating. Key offerings encompass acids, alkaline compounds, and food-grade and pharmaceutical-quality salts and components. Furthermore, this segment manages the receipt, storage, and distribution of various bulk chemicals, such as liquid caustic soda, sulfuric acid, hydrochloric acid, urea, phosphoric acid, aqua ammonia, and potassium hydroxide. Manufacturing activities involve sodium hypochlorite, agricultural commodities, and a range of food-grade and pharmaceutical items like liquid phosphates, lactates, and custom blends. Additionally, the segment provides repackaging services for water treatment and bulk industrial chemicals, custom chemical blending, and contract and private-label packaging for bleach products. The Water Treatment division furnishes chemicals, equipment, and tailored solutions for applications in potable water, municipal and industrial wastewater management, industrial process water, and non-residential swimming pool and agricultural water systems. The Health and Nutrition division delivers ingredient procurement, processing, and formulation services to manufacturers specializing in nutraceuticals, functional foods and beverages, personal care items, dietary supplements, and other nutritional and health & wellness products. Its product portfolio features minerals, botanicals and herbal extracts, vitamins and amino acids, excipients, joint support products, sweeteners, and enzymes. The company, established in 1938, maintains its headquarters in Roseville, Minnesota.

Analyst Sentiment

75%
Strong Buy

From 4 Active Polls

1Y Forecast: $142.00

▲ +10.9% Potential Upside

Consensus Target Metrics

Low Bound

$142

Median

$142

High Bound

$142

Average

$142

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$142.00
▲ +10.91% Upside
Low Target
$142.00
11% Risk
Median Target
$142.00
11% Mid
High Target
$142.00
11% Max
Consensus
Buy
1 / 2 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period EndingTrailing 12MJun 28, 2026Mar 29, 2026Dec 28, 2025Sep 28, 2025Jun 29, 2025Mar 30, 2025Dec 29, 2024Sep 29, 2024
Market Cap ($M)2,6732,9383,1463,0543,6692,9442,1962,5682,646
Enterprise Value ($M)2,9223,1883,4043,3243,9523,2382,3532,6842,752
Price to Earnings Ratio (P/E)32.9125.9950.5453.3640.5825.2033.5242.9327.47
Price/Earnings-to-Growth Ratio (PEG)1.395.651.293.97
Price to Sales Ratio (P/S)2.429.3111.8312.5113.0810.048.9511.3510.71
Price to Book Ratio (P/B)4.855.365.895.897.246.084.775.625.97
Price to Free Cash Flow Ratio (P/FCF)29.15124.77173.27143.80127.64164.05111.14208.5185.37
Enterprise Value to Sales (EV/Sales)10.1012.8013.6214.0911.049.5911.8611.14
Enterprise Value to EBITDA (EV/EBITDA)16.7158.9893.3291.2682.4659.3468.1584.9062.06
Debt to Equity Ratio1.430.470.490.540.580.640.350.270.26

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

```html

📘 HAWKINS INC (HWKN) — Investment Overview

🧩 Business Model Overview

HAWKINS INC operates in the specialty chemicals value chain, serving customers with water treatment and industrial process chemicals. The company typically sources chemicals and related inputs, maintains inventories, and delivers products in formats matched to customer dosing and application requirements (bulk supply, packaged chemicals, and related operational support). A meaningful portion of value creation comes from helping customers solve ongoing water quality and process control needs through technical guidance, product selection, and supply reliability—reducing the operational friction of qualifying and re-qualifying chemical programs.

The business model tends to be “application- and qualification-led”: once a chemical program is validated for performance, compatibility, and safety within a customer’s system, purchasing decisions become more continuous and operationally embedded than a one-off commodity purchase.

💰 Revenue Streams & Monetisation Model

Revenue is primarily generated through sales of chemicals used in water treatment and industrial processes. Monetisation is generally driven by a mix of:

  • Recurring replenishment sales tied to ongoing system operation (municipal water, wastewater, industrial boilers, cooling, and process streams).
  • Contractual or semi-contracted pricing structures where product costs and customer demand influence realized pricing over time.
  • Transactional volume sales associated with customer production schedules, maintenance cycles, and incremental capacity additions.

Margin drivers typically include (1) the mix of specialty versus more commoditized inputs, (2) inventory and distribution execution (availability and spoilage/safety controls), and (3) the ability to manage freight, logistics, and pass-through mechanics when underlying input costs move. Because customer consumption is ongoing, operating models with consistent service levels can support revenue stability even through broader demand cycles.

🧠 Competitive Advantages & Market Positioning

HAWKINS’ competitive moat is best characterized as a combination of switching costs and logistics/distribution execution, supported by technical know-how.

  • Switching costs (chemical qualification + performance history): Water treatment performance depends on chemistry compatibility, dosing precision, and system-specific operating conditions. Customers build operational history with a provider’s product portfolio and application guidance, making replacement more effortful than switching a generic input.
  • Logistics and supply reliability: Local delivery capability, inventory positioning, and disciplined handling of hazardous/regulated materials reduce downtime risk for customers. Reliability can be a determinative factor for procurement decisions, especially where process interruptions carry high costs.
  • Technical support and application knowledge: Application guidance lowers the trial-and-error burden for customers and improves the probability that product programs meet targets (e.g., corrosion control, scale inhibition, disinfection efficiency, wastewater treatment performance).

Competitive benchmarking:

  • Ecolab and Solenis (water treatment chemicals and systems): These firms often compete through deeper global product breadth and integrated service offerings. Their scale and vertical integration can pressure distributor economics, but they may require less direct local distribution presence in certain markets.
  • Kemira (water and industrial treatment chemicals): Kemira competes with a specialty portfolio and production scale. Hawkins competes by emphasizing supply execution, practical application support, and customer responsiveness in served territories.
  • Univar Solutions and Brenntag (chemical distribution): These distributors compete on reach and breadth across end markets. Hawkins’ differentiation is the depth of focus on water treatment and industrial applications, where qualification, reliability, and operational integration can matter more than “one-stop” breadth alone.

In contrast to global integrated producers that emphasize manufacturing scale and bundled systems, Hawkins’ industry focus tends to center on customer-specific chemical programs supported by distribution reliability and technical application execution—an approach that can reinforce stickiness through switching friction.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, growth can be supported by structural demand drivers that increase chemical consumption and expand treatment requirements:

  • Municipal and industrial water infrastructure upgrades: Aging assets, capacity expansions, and modernization of treatment facilities typically increase chemical intensity and reliability requirements.
  • Regulatory tightening and contaminants management: More stringent discharge and treatment standards can increase the complexity of water programs and the need for specialized chemistries and dosing strategies.
  • Industrial process utilization and efficiency programs: Manufacturing, power, and energy-adjacent end markets often require continuous water conditioning for corrosion/scaling control and process stability.
  • Operational compliance and safety expectations: The need for disciplined chemical handling, documentation, and consistent supply favors providers with robust logistics and compliance capabilities.

TAM expansion for the company is therefore linked less to “new product hype” and more to the long-lived need for water and process treatment across municipal services and industrial operations.

⚠ Risk Factors to Monitor

  • Input cost volatility and pricing lag: Chemical feedstocks and energy-related inputs can move materially. Persistent pricing lags can pressure gross margins if pass-through mechanisms do not keep pace.
  • Working capital intensity: Inventory build strategies, supplier terms, and delivery cycles influence cash conversion. Material working capital swings can affect free cash flow even when earnings remain stable.
  • Customer concentration and procurement centralization: Large accounts may consolidate suppliers, renegotiate pricing, or internalize procurement processes.
  • Regulatory and environmental compliance burden: Handling, storage, and transportation of regulated materials impose ongoing compliance costs and operational risk.
  • Competitive pressure from integrated providers: Integrated chemical and systems competitors may bundle service and capture wallet share, especially where customers prioritize turnkey solutions.

📊 Valuation & Market View

Specialty chemical and water-treatment-linked businesses are often valued on earnings durability rather than one-time growth. Market focus typically centers on:

  • Operating margins and gross margin stability (ability to manage input cost cycles and maintain specialty mix).
  • Quality of revenue (replenishment/recurring characteristics vs. purely cyclical volume dependence).
  • Return on invested capital (distribution/inventory efficiency and cash conversion).
  • Downside protection from supply reliability and switching friction, which can support steadier demand and pricing power.

As a result, valuation typically responds most to evidence of resilient margin structure, disciplined working capital management, and sustained customer retention supported by technical and logistical execution.

🔍 Investment Takeaway

HAWKINS INC presents a defensible long-term thesis built on customer switching friction (chemical qualification and performance history), complemented by logistics and supply reliability in a regulated, operationally critical materials category. Over time, demand tailwinds from water infrastructure modernization and increasingly complex treatment requirements can support steady chemical consumption, while the company’s ability to manage input cost dynamics and maintain execution quality can drive durable profitability.


⚠ AI-generated — informational only. Validate using filings before investing.

```

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for HWKN.

zacks.com2026-07-29

Hawkins (HWKN) Q1 Earnings Lag Estimates

Hawkins (HWKN) came out with quarterly earnings of $1.35 per share, missing the Zacks Consensus Estimate of $1.41 per share. This compares to earnings of $1.4 per share a year ago.

globenewswire.com2026-07-29

Hawkins, Inc. Reports First Quarter Fiscal 2027 Results

ROSEVILLE, Minn., July 29, 2026 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) today announced results for the three months ended June 28, 2026, its first quarter of fiscal 2027.

globenewswire.com2026-07-29

Hawkins, Inc. Increases its Quarterly Cash Dividend by 5% to $0.20 Per Share

ROSEVILLE, Minn., July 29, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Hawkins, Inc. (Nasdaq: HWKN), at its meeting on July 29, 2026, increased its quarterly cash dividend by 5% to $0.20 per share, payable August 28, 2026, to shareholders of record at the close of business on August 14, 2026.

defenseworld.net2026-07-27

Caxton Associates LLP Acquires New Shares in Hawkins, Inc. $HWKN

Caxton Associates LLP bought a new position in Hawkins, Inc. (NASDAQ: HWKN) during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 5,166 shares of the specialty chemicals company's stock, valued at approximately $793,000. A number of other hedge funds and other institutional

zacks.com2026-07-23

AXTA vs. HWKN: Which Stock Is the Better Value Option?

Investors looking for stocks in the Chemical - Specialty sector might want to consider either Axalta Coating Systems (AXTA) or Hawkins (HWKN). But which of these two stocks is more attractive to value investors?

globenewswire.com2026-07-15

Hawkins, Inc. to Release First Quarter Fiscal 2027 Financial Results on July 29, 2026

ROSEVILLE, Minn., July 15, 2026 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) announced today that it expects to release its financial results for its first quarter fiscal 2027 ended June 28, 2026 after the market closes on July 29, 2026 at approximately 4:10 p.m. Eastern Time.

zacks.com2026-06-25

FUPBY or HWKN: Which Is the Better Value Stock Right Now?

Investors with an interest in Chemical - Specialty stocks have likely encountered both FUCHS SE - Unsponsored ADR (FUPBY) and Hawkins (HWKN). But which of these two stocks presents investors with the better value opportunity right now?

zacks.com2026-06-09

FUPBY vs. HWKN: Which Stock Is the Better Value Option?

Investors looking for stocks in the Chemical - Specialty sector might want to consider either FUCHS SE - Unsponsored ADR (FUPBY) or Hawkins (HWKN). But which of these two companies is the best option for those looking for undervalued stocks?

seekingalpha.com2026-06-07

Hawkins: A Track Record Of Growth But It's Overvalued (Rating Downgrade)

Hawkins is rated a 'sell' due to significant overvaluation versus historical averages and rising leverage from aggressive M&A. HWKN's growth-by-acquisition strategy, especially in water treatment, has driven revenue and EPS. Debt, leverage, and interest expense are rising; operating margins have declined to 10.4%, and interest coverage has dropped below 9x.

seekingalpha.com2026-06-05

Dividend Champion, Contender, And Challenger Highlights: Week Of June 7

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.

gurufocus.com2026-05-29

Hawkins Inc (HWKN) Shares Fall 3.2% -- GF Value Says Still Overvalued

On May 29, 2026, Hawkins Inc (HWKN) shares fell 3.2% to $154.75, bringing the stock down from its recent highs. Over the past 52 weeks, the stock has fluctuated

zacks.com2026-05-20

FUL or HWKN: Which Is the Better Value Stock Right Now?

Investors interested in Chemical - Specialty stocks are likely familiar with H. B. Fuller (FUL) and Hawkins (HWKN).

zacks.com2026-05-13

Hawkins (HWKN) Q4 Earnings Miss Estimates

Hawkins (HWKN) came out with quarterly earnings of $0.74 per share, missing the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $0.78 per share a year ago.

gurufocus.com2026-05-13

Hawkins Inc (HWKN) Shares Fall 4.0% -- GF Value Says Still Overvalued

On May 13, 2026, Hawkins Inc (HWKN) shares fell 4.0%, closing at $161.83. The stock has experienced volatility, trading within a 52-week range of $115.35 to $18

globenewswire.com2026-05-13

Hawkins, Inc. Reports Fourth Quarter and Fiscal Year 2026 Results

ROSEVILLE, Minn., May 13, 2026 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) today announced fourth quarter and full-year results for its fiscal year ended March 29, 2026.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-06-28

"Headline (2026-06-28, Q1): Revenue $315.7M; Net Income $28.3M; EPS $1.36. YoY growth (Q1’26 vs Q1’25): Revenue +7.7% (315.7 vs 293.3), Net Income -3.1% (28.3 vs 29.2). QoQ growth (Q1’26 vs Q4’25): Revenue +18.8% (315.7 vs 265.9), Net Income +82.8% (28.3 vs 15.5). Profitability improved sharply on a QoQ basis: net margin expanded from 5.8% (Q4) to 9.0% (Q1), while gross margin improved to 23.4% from 20.4%. Over the broader 4-quarter run, margins have been volatile—net margin was ~6.8%–10.0% previously—suggesting operating leverage is present but not fully consistent. Cash flow quality remains solid: operating cash flow was $35.2M and free cash flow $23.5M in the quarter, supporting a dividend payout of ~$4.0M (payout ratio ~14% of net income). Balance sheet resilience is mixed: total assets were ~$1.01B, but long-term debt remains elevated at $257.7M with net debt still high (~$249.7M) and cash low (~$8.0M). Shareholder returns are supportive given the stock’s 1-year price momentum of +24.6% (dividend yield ~0.14%), lifting total shareholder return. Analyst sentiment appears neutral to mildly constructive given a consensus price target of $170 vs ~$151.08 current (~+12.5% upside)."

Revenue Growth

Positive

QoQ revenue accelerated to $315.7M (+18.8% vs $265.9M). YoY revenue growth is positive but moderate at +7.7% (vs $293.3M).

Profitability

Positive

Net margin expanded QoQ to 9.0% from 5.8% and operating income increased to $38.7M (from $22.1M). However, YoY net income declined -3.1%, indicating profitability strength has not fully persisted versus last year.

Cash Flow Quality

Good

Strong cash conversion in the quarter: operating cash flow $35.2M and free cash flow $23.5M. Dividends paid ~$4.0M with a conservative payout ratio (~14%), suggesting reasonable near-term dividend coverage.

Leverage & Balance Sheet

Fair

Non-bank leverage remains meaningful: long-term debt ~$257.7M and net debt ~$249.7M with low cash (~$8.0M). Equity is sizable (~$548M) but resilience is constrained by debt and limited liquid buffers.

Shareholder Returns

Good

Total return support from strong price momentum: +24.6% 1-year change. Dividend yield is low (~0.14%), so appreciation is doing most of the work.

Analyst Sentiment & Valuation

Neutral

Consensus target $170 vs current ~$151.08 implies ~+12.5% upside. Valuation looks demanding on earnings (P/E ~26x) and cash flow, so execution risk remains.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for HWKN.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (HWKN)

© 2026 Stock Market Info — Hawkins, Inc. (HWKN) Financial Profile